Continuing Regeneration of Our Spring Meeting (Now there are fi ve organizations!)
H. Selker
DOI: https://doi.org/10.1111/j.1752-8062.2011.00266.x
2011-02-01
Clinical and Translational Science
Abstract:and Translational Research and Education Meeting, April 27–29, at the Omni Shoreham Hotel in Washington, DC. Th is year, besides again being cosponsored by Association for Clinical Research Training (ACRT) and the Society for Clinical and Translational Science (SCTS), and again with the participation of the Association for Patient-Oriented Research (APOR), two additional outstanding organizations dedicated to clinical and translational science are joining us. Th e American Federation for Medical Research (AFMR) will be a joint cosponsor of the meeting, and the Clinical Research Forum will have its Annual Meeting concomitantly at the same site, including with participation in some sessions. Starting in 2005 with the return of the “Spring Meetings” to the Shoreham/Wardman Park location in Washington, DC, this year’s meeting represents the continued regeneration of those special meetings that were at the core of the clinical research enterprise. Th e three most common defi nitions of “regeneration” are: (1) the act or process of regenerating, (2) spiritual or moral revival or rebirth, and (3) in biology, the regrowth or reforming lost or destroyed parts or organs. Each of these, to some extent, might legitimately be applied as a metaphor for the meeting. In this case, a new defi nition might be added: the re-forming of a prior institution by a new generation. Th e Spring Meetings tradition dates back 125 years, a general meeting focused on what we would now call clinical and translational science, with joint meeting sponsorship that has long included trainees and junior through the most senior faculty investigators, originally including the Association of American Physicians (AAP), the Association for Clinical Investigation (ASCI), and the AFMR (then AFCR). However, aft er a century of convivial scientifi c exchange every spring, with the rise of specialty, sub-, and sub-sub-specialty meetings, and with increasing demands on investigators’ time, over the end of the last century, there was a move away from this general cross-disciplinary meeting to more narrow gatherings. Ultimately, a decade ago, infl uenced by these factors, and shift s in the original partner organizations’ objectives, the Spring Meetings split up and left Washington, DC. Yet, even at the time of the dissolution of the joint meeting, many long-time attendees, augmented by researchers and National Institutes of Health (NIH) who were refocusing on the importance of cross-disciplinary clinical research, were looking for regeneration. In 2005, there was a return to the scene of the original Spring Meetings in Washington, which I had the privilege to chair as Clinical Research 2005, as a joint meeting of ACRT, the General Clinical Research Center Program Directors, and AFMR—with APOR in attendance as well. Now, with some diff erent organizational labels, there is new zeal to advance cross-cutting clinical research and training. Importantly, this was the dawning of the age of Clinical and Translational Science Awards (CTSAs). At that meeting, NIH Director, Elias Zerhouni, announced the formation of the CTSA program, intended to transform biomedical research and education to facilitate groundbreaking research and to maximize impact on health. Th us, began the regeneration of our Spring Meeting back at its old site. Th e addition of these two new organizations to our joint meeting is organically consistent with the continued regeneration of our Spring Meeting. Both are focused on clinical and translational science, ranging from trainees (AFMR) to senior leaders (Clinical Research Forum), and are completely compatible with the current partners, SCTS, which represents major crosscutting clinical and translational science organizations, ACRT, which focuses on training and career development in this area, and APOR, which has promoted the return to patient-oriented research. Yet, consistent with the very title of this relatively new journal, it should be noted that these organizations each reflect important updating in the field—there is now a new focus on translational research. There is a new understanding of our mission and responsibility as scientists. We now are very aware that doing science and publishing articles that ultimately do not impact the health of the public is falling short of our ultimate mission as biomedical researchers—and of the legitimate expectations of the public. We now focus on the full T1-T4 spectrum of clinical and translational research: from bench to bedside, T1, from bedside to practice, T2, and then to widespread clinical practice and to public health measures and policy, T3 and T4. This emphasis is decidedly different, and correspondingly the meeting is now much more focused on this full spectrum. As was clear at last year’s meeting, there is a major focus on how, by improving research, the research environment, education, and career development, we can increase our ultimate impact on health. If you once enjoyed the great science and camaraderie of the old Spring Meetings, you will find that again in the regenerated one, but now with even more commitment and focus on our mission as scientists seeking to ultimately improve human health. Th e meeting program illustrates this breadth of disciplines and focus on impact on health (see http://acrtraining.org/2011annual-meeting/fi nd-out-more). Aimed at researchers, trainees, educators, and others engaged in fi eld of clinical and translational science, the meeting will have sessions that range from the latest research methods and processes to presentations by our nation’s leaders of biomedical research and its translation into practice. For example, a plenary session will include government leaders speaking on “Translational Research: Innovations and Practical Strategies to Improve Health,” which will include Margaret (“Peggy”) Hamburg, MD, Commissioner of the Food and Drug Administration, Francis Collins, MD, PhD, NIH Director, and Donald Berwick, MD, Administrator of Centers for Medicare & Medicaid. A related plenary session will be, “Th e Transformation of NIH: Where Are We and Where Are